蓝帆医疗
(002382)
| 流通市值：54.38亿 | | | 总市值：54.79亿 |
| 流通股本：10.00亿 | | | 总股本：10.07亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 4,181,728,803.56 | 2,780,551,449.68 | 1,477,911,477.13 | 6,253,168,236.58 |
| 营业收入 | 4,181,728,803.56 | 2,780,551,449.68 | 1,477,911,477.13 | 6,253,168,236.58 |
| 二、营业总成本 | 4,540,279,927.07 | 2,960,366,551.91 | 1,508,152,236.39 | 6,620,497,143.37 |
| 营业成本 | 3,610,323,665.65 | 2,381,801,341.21 | 1,224,199,609.93 | 5,222,701,975.08 |
| 税金及附加 | 39,027,857.89 | 23,710,145.16 | 12,143,832.56 | 42,138,967.02 |
| 销售费用 | 332,425,100 | 214,511,264.44 | 91,890,359.91 | 465,976,276.08 |
| 管理费用 | 226,080,232.83 | 148,604,568.21 | 69,509,328.6 | 348,509,007.38 |
| 研发费用 | 192,637,377.01 | 122,304,096.36 | 68,114,361 | 341,915,007.55 |
| 财务费用 | 139,785,693.69 | 69,435,136.53 | 42,294,744.39 | 199,255,910.26 |
| 其中:利息费用 | 205,741,051.68 | 137,452,699.13 | 70,545,959.16 | 278,979,702.23 |
| 其中:利息收入 | 20,255,835.07 | 14,202,391.71 | 6,962,972.45 | 30,384,815.97 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 6,606,212.02 | 6,523,442.42 | 127,910,871.77 | 6,541,868.72 |
| 加:投资收益 | 13,481,981.59 | 5,592,656.84 | 1,798,623.76 | -7,474,359.78 |
| 资产处置收益 | -411,420.42 | -372,425.04 | 106,916.49 | -839,222.11 |
| 资产减值损失(新) | -45,173,647.69 | -68,260,025.29 | -45,865,732.57 | -53,735,642.88 |
| 信用减值损失(新) | -8,068,920.4 | 2,674,632.21 | 3,877,232.87 | -24,706,929.91 |
| 其他收益 | 46,209,170.12 | 41,978,303.89 | 13,905,108.26 | 30,979,097.13 |
| 四、营业利润 | -345,907,748.29 | -191,678,517.2 | 71,492,261.32 | -416,564,095.62 |
| 加:营业外收入 | 2,442,771.57 | 2,266,552.94 | 394,778.73 | 21,298,978.61 |
| 减:营业外支出 | 4,225,285.77 | 2,690,037.16 | 883,092.6 | 6,338,794.4 |
| 五、利润总额 | -347,690,262.49 | -192,102,001.42 | 71,003,947.45 | -401,603,911.41 |
| 减:所得税费用 | -44,994,047.5 | -49,283,013.74 | -11,529,996.09 | 63,317,316.2 |
| 六、净利润 | -302,696,214.99 | -142,818,987.68 | 82,533,943.54 | -464,921,227.61 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -302,696,214.99 | -142,818,987.68 | 82,533,943.54 | -464,921,227.61 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -285,962,030.51 | -134,779,268.14 | 77,022,348.52 | -445,608,865.62 |
| 少数股东损益 | -16,734,184.48 | -8,039,719.54 | 5,511,595.02 | -19,312,361.99 |
| 扣除非经常损益后的净利润 | -364,366,368.11 | -209,757,631.99 | -60,790,742.49 | -479,857,621.27 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.28 | -0.13 | 0.08 | -0.44 |
| (二)稀释每股收益 | -0.28 | -0.13 | 0.08 | -0.44 |
| 八、其他综合收益 | -12,376,023.67 | 26,574,975.36 | 2,412,969.11 | 27,426,379.65 |
| 归属于母公司股东的其他综合收益 | -8,952,690.58 | 23,247,327.47 | 2,556,983.3 | 22,518,852.99 |
| 九、综合收益总额 | -315,072,238.66 | -116,244,012.32 | 84,946,912.65 | -437,494,847.96 |
| 归属于母公司股东的综合收益总额 | -294,914,721.09 | -111,531,940.67 | 79,579,331.82 | -423,090,012.63 |
| 归属于少数股东的综合收益总额 | -20,157,517.57 | -4,712,071.65 | 5,367,580.83 | -14,404,835.33 |
| 公告日期 | 2025-10-31 | 2025-08-30 | 2025-04-29 | 2025-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |